Jasbir Seehra
2021
In 2021, Jasbir Seehra earned a total compensation of $7.2M as Chief Executive Officer and Director at Keros Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $348,000 |
|---|---|
| Option Awards | $6,325,872 |
| Salary | $556,800 |
| Other | $3,287 |
| Total | $7,233,959 |
Seehra received $6.3M in option awards, accounting for 87% of the total pay in 2021.
Seehra also received $348K in non-equity incentive plan, $556.8K in salary and $3.3K in other compensation.
Rankings
In 2021, Jasbir Seehra's compensation ranked 1,672nd out of 12,406 executives tracked by ExecPay. In other words, Seehra earned more than 86.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,672 out of 12,406 | 87th |
Division Manufacturing | 613 out of 5,492 | 89th |
Major group Chemicals And Allied Products | 227 out of 2,368 | 90th |
Industry group Drugs | 190 out of 2,089 | 91st |
Industry Pharmaceutical Preparations | 127 out of 1,536 | 92nd |
Source: SEC filing on April 18, 2022.
Seehra's colleagues
We found two more compensation records of executives who worked with Jasbir Seehra at Keros Therapeutics in 2021.